# CYTOKINETICS INC (CYTK)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CYTK/

- Reporting holders: 10
- Reported value: $14.8M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Mirador Capital Partners LP](https://holderbook.com/funds/1633446-mirador-capital-partners-lp/) | $13.8M | 208,896 | 1.6% | 28 |
| [Veracity Capital LLC](https://holderbook.com/funds/1811005-veracity-capital-llc/) | $489.1K | 7,420 | 0.1% | 21 |
| [Breakwater Capital Group](https://holderbook.com/funds/1964309-breakwater-capital-group/) | $259.8K | 3,941 | 0.0% | 5 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $178.0K | 2,700 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $46.9K | 712 | 0.0% | 15 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $24.8K | 376 | 0.0% | 19 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $7.5K | 114 | 0.0% | 4 |
| [ELEVATION WEALTH PARTNERS, LLC](https://holderbook.com/funds/1976256-elevation-wealth-partners-llc/) | $4.9K | 74 | 0.0% | 2 |
| [Trust Co](https://holderbook.com/funds/1632554-trust-co/) | $659 | 10 | 0.0% | 4 |
| [GILPIN WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/2058144-gilpin-wealth-management-llc/) | $132 | 2 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 10 | $14.8M |
| Q2 2026 | 493 | $15.4B |
| Q1 2026 | 452 | $10.5B |
| Q4 2025 | 438 | $10.1B |
| Q3 2025 | 389 | $8.3B |
| Q2 2025 | 318 | $4.8B |
| Q1 2025 | 357 | $5.7B |
| Q4 2024 | 353 | $6.5B |
| Q3 2024 | 357 | $7.7B |
| Q2 2024 | 358 | $7.7B |
| Q1 2024 | 400 | $9.5B |
| Q4 2023 | 368 | $12.2B |